MCED blood test trial fails primary end point, but screening cut number of cancers found at stage IV
Dr Michael Betti speaks to ecancer about a transcriptome-wide association study in 4,279 childhood cancer survivors from the St. Jude Lifetime Cohort Study.
The study identifies genetically regulated gene and enhancer RNA expression associated with the risk of subsequent neoplasms. Several associations were replicated in the Childhood Cancer Survivor Study and supported by differential expression in subsequent tumour tissue.
Dr Betti says that the analysis also identified gene-treatment interactions, including associations modified by chemotherapy and radiation exposure, providing insights into the biological mechanisms underlying subsequent cancer risk and potential approaches to future risk stratification.
MCED blood test trial fails primary end point, but screening cut number of cancers found at stage IV
Part 1: Why test?
Part 2: How to get biopsies for testing?
ctDNA predicts early treatment response in HPV-associated anal cancer
Microplastics found at higher levels in prostate cancer tissue compared to benign tissue
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
SABCS 2025: Latest developments in multigene testing in early breast cancer
Insights into germline genetic screening of breast cancer patients
Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer